Adv Ther, 2023 · DOI: https://doi.org/10.1007/s12325-023-02563-5 · Published: July 7, 2023
Spasticity is an abnormal, involuntary muscle tightness due to extended muscle contraction. This resistance in movement can be caused by stroke, multiple sclerosis, or traumatic injuries to the brain or spinal cord. Cervical dystonia is a form of sustained involuntary muscle contractions that result in abnormal or repetitive muscle movements in the neck and upper shoulders. This study was conducted to better understand BoNT-A injection patterns, use of healthcare services, and the resulting costs in patients with spasticity or cervical dystonia.
The study results can inform insurers' BoNT-A category management strategies, enabling them to optimize resource allocation and potentially reduce healthcare costs associated with spasticity and cervical dystonia treatments.
The finding that aboBoNT-A is associated with the lowest injection costs may guide clinicians in making more cost-effective treatment decisions when managing patients with spasticity or cervical dystonia.
Further research is warranted to understand the drivers of cost differences among different BoNT-A toxins, potentially leading to more targeted and efficient treatment strategies.